光热治疗
生物物理学
生物相容性
热休克蛋白
化学
纳米颗粒
荧光
光敏剂
两亲性
热疗
肽
降级(电信)
热休克蛋白70
活性氧
光热效应
蛋白质降解
热冲击
体内
光化学
分子
热休克蛋白90
纳米技术
小分子
材料科学
绿色荧光蛋白
生物化学
原位
作者
Yating Wang,Yixuan Xu,Dejia Chen,Dalong Yin,Lifeng Yan
出处
期刊:
[American Chemical Society]
日期:2026-08-29
卷期号:1 (9): 2471-2483
标识
DOI:10.1021/acsnanomed.6c00172
摘要
Abstract Abstract photothermal therapy (PTT) usually results in the increase of heat shock proteins (HSPs), which leads to side effects and low efficiency. Protein degradation-targeting chimeras (PROTAC) provides a chance to degrade the HSPs, but the smart PROTAC during PTT is still scarce. Here, we designed and constructed a PROTAC-loaded peptide nanoparticle (PJS) for near-infrared II (NIR-II) fluorescence imaging-guided and mild tumor photothermal/photodynamic synergistic therapy. The nanoparticles self-assembled from acid-sensitive amphiphilic polypeptides, encapsulating both the photodynamic/photothermal dual-effect photosensitizer TPBr-Cy and the PROTAC molecules targeting heat shock protein 90 (HSP90) degradation. PJS exhibited good biocompatibility and responsiveness to the acidic tumor microenvironment. Upon accumulation at tumor sites and responsive release, the enhanced fluorescence signal of TPBr-Cy enabled high-resolution NIR-II fluorescence imaging, providing navigation for precision therapy. Under single near-infrared laser irradiation, PJS simultaneously generated reactive oxygen species (ROS) for PDT effects while effectively maintaining local temperatures within the mild photothermal range (∼45 °C), minimizing the thermal damage to surrounding normal tissues. Crucially, the released PROTAC molecules specifically degraded HSP90 protein, effectively disrupting tumor cells’ heat defense mechanisms under mild thermal stress and significantly enhancing sensitivity to mild photothermal therapy. This intelligent responsive peptide nanoplatform, integrating NIR-II imaging, PROTAC-mediated protein degradation, PDT, and mPTT, demonstrated promising synergistic antitumor effects.
科研通智能强力驱动
Strongly Powered by AbleSci AI